A report from TheBusinessResearchCompany shows that the "Global Lung Cancer Drugs Market 2019" is expected to grow to $22.98 billion at a CAGR of 6.9% through 2022.
The Business Research Company’s Lung Cancer Drugs Global Market Report 2019 covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and ... Read more
TheBusinessResearchCompany published its Lung Cancer Drugs Global Market Report 2020 which provides strategists, marketers and senior management with the critical information they need to assess the global lung cancer drugs market. The report covers the lung cancer drugs market’s segments- small cell lung cancer (SCLC), non-small cell lung cancer (NSCLC), hospitals, clinics, gemzar, paraplatin, taxotere, navelbine, avastin, tarceva, iressa, and others.